$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
利鲁唑片在医保范围内吗?
2025-10-19 11:44:20
Check Details
治疗肌萎缩侧索硬化症有效药物利鲁唑片
2025-10-19 11:44:20
Check Details
利鲁唑片(力如太)能延长多久寿命?
2025-10-19 11:44:20
Check Details
利鲁唑片需要服用多长时间?
2025-10-19 11:44:20
Check Details
利鲁唑片治疗肌萎缩侧索硬化症疗效怎么样?
2025-10-19 11:44:20
Check Details
利鲁唑片主治什么?
2025-10-19 11:44:20
Check Details
利鲁唑片的用途和价格
2025-10-19 11:44:20
Check Details
利鲁唑片医保能报销吗?
2025-10-19 11:44:20
Check Details
力如太可以治好肌萎缩侧索硬化吗?
2025-10-19 11:44:20
Check Details
FDA批准力如太用于肌萎缩侧索硬化症的治疗
2025-10-19 11:44:20
Check Details
力如太治疗肌萎缩侧索硬化症的效果
2025-10-19 11:44:20
Check Details
肌萎缩侧索硬化用药力如太效果如何?
2025-10-19 11:44:20
Check Details
1
2
...
3234
3235
3236
3237
3238
3239
3240
...
10230
10231
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Capmatinib (Tabrecta): Oral Targeted Therapy for MET Exon 14 Skipping-Mutated NSCLC
2
Amivantamab Plus Lazertinib: A Chemotherapy-Free First-Line Option in EGFR-Mutated NSCLC
3
Midostaurin (Rydapt): Dosing Essentials in FLT3-Mutated AML and Systemic Mastocytosis
4
Lapatinib: An Oral Dual EGFR/HER2 TKI in HER2-Positive Breast Cancer
5
Filgotinib (Jyseleca) Overseas Guide: JAK1 Inhibitor for Rheumatoid Arthritis and Ulcerative Colitis
6
FDA Approves LISRAYA (brepocitinib): First Oral Targeted Therapy for Adults with Dermatomyositis
7
Elagolix for Endometriosis Pain: Indications and Usage Guidelines
8
Bosentan vs. Antihypertensives: What PAH Patients Need to Know
9
Letermovir: Proper Usage and Important Precautions
10
FDA Approves Daraxonrasib, Marking Milestone in Metastatic Pancreatic Cancer Treatment
11
Brensocatib for Non-Cystic Fibrosis Bronchiectasis: Patient Selection, ASPEN Data, and Safety Profile
12
Mirdametinib Mechanism and Clinical Guide: MEK Inhibitor for NF1 Plexiform Neurofibromas